ENTITY
Bayer

Bayer (BAYN GR)

70
Analysis
Health Care • Germany
Bayer AG produces and markets healthcare and agricultural products. The Company manufactures products that include aspirin, antibiotics, anti-infectives, cardiovascular, oncology, central nervous system drugs, over-the-counter medications, diagnostics, and animal health products, as well as crop protection products, plastics, and polyurethanes.
more
•27 Feb 2017 14:28

AI & Machine Learning Disrupting The Healthcare Industry

In the omnipresence of machine learning, one of the most impacted segments is healthcare. Not only is AI in healthcare at the forefront of a...

Logo
695 Views
Share
bearish•Monsanto Co
•09 Feb 2017 21:58

Monsanto / Bayer: International Antitrust Reviews

Antitrust regulators’ protocols and assessments of mergers differ by jurisdiction and this insight focuses almost exclusively on the international...

Share
•08 Feb 2017 09:38

If Reckitt Benckiser Buys Mead Johnson Then Is a Home Care Spinoff Next?

Reckitt Benckiser Group (RB) is currently in “advanced” talks to buy Mead Johnson Nutrition Co for USD16.7 billion, in a deal that makes little...

•30 Jan 2017 13:50

Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

AML represents one of the largest hematologic cancer populations with one of the worst survival rates. Global prevalence is expected to increase at...

bearish•Nufarm Ltd
•25 Jan 2017 10:01

Our AUD 6.00 Nufarm Fair Value Estimate Stands Despite Share Price Strength

Our AUD 6.00 fair value estimate is unchanged. Nufarm shares have largely held on to the strong 40% price gains from AUD 6.30 February 2016 lows,...

Share
x